Production and Characterization of Novel Ssrna Bacteriophage Virus

Production and Characterization of Novel Ssrna Bacteriophage Virus

Liekniņa et al. J Nanobiotechnol (2019) 17:61 https://doi.org/10.1186/s12951-019-0497-8 Journal of Nanobiotechnology RESEARCH Open Access Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data Ilva Liekniņa, Gints Kalniņš, Ināra Akopjana, Jānis Bogans, Mihails Šišovs, Juris Jansons, Jānis Rūmnieks and Kaspars Tārs* Abstract Background: Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few diferent VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unrave- led numerous ssRNA phage genomes signifcantly diferent from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs. Results: Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 diferent clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purifcation of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfde bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identifed that might bind to the coat protein and ensure specifc RNA packaging. Conclusions: Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new parti- cles representing ten distinct similarity groups are now available with a notable potential for biotechnological applica- tions. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. Background shell about 28 nm in diameter with an underlying T = 3 Te single-stranded RNA (ssRNA) bacteriophages of quasi-equivalent icosahedral symmetry. Te capsid is the Levivirdae family are small viruses that infect a vari- constituted of the major coat protein (CP) and one or ety of Gram-negative bacteria. Teir virions consist of a two species of minor structural proteins that are involved compact, approximately 3500 to 4200 nucleotide-long in recognition and packaging of the genome and are genome packaged in a small, spherical-looking protein required to adsorb the virion to the bacterial receptor and convey the RNA genome into the cell. At least for the currently studied ssRNA phages, the minor virion pro- *Correspondence: [email protected] teins are not essential either for assembly or for structural Latvian Biomedical Research and Study Center, Rātsupītes 1, Riga LV1067, Latvia integrity of the protein shell, and recombinant expression © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/ publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Liekniņa et al. J Nanobiotechnol (2019) 17:61 Page 2 of 14 of a cloned coat protein gene results in the appearance of considerable interest for continued developments in the virus-like particles (VLPs) that are morphologically very area. similar to native virions but have spontaneously pack- While no novel ssRNA phages have been isolated lately, aged bacterial RNA inside the particles instead of the the increasing metagenomic sequencing eforts in recent genome [1–4]. years have uncovered a previously unknown diversity of Te ssRNA phage VLPs have found a variety of applica- these viruses in nature. In 2015, genomes of two novel tions, mostly in the feld of vaccine development where Leviviridae phages EC and MB were assembled from San various antigens are presented onto the capsid surface to Francisco wastewater [18], and soon a much wider study invoke a strong immune response. Phage Qβ VLPs con- revealed over 150 partial ssRNA phage sequences in dif- jugated with various peptide and small-molecule moie- ferent RNA metagenomes [19]. A survey of RNA virus ties have reached clinical trials against conditions such sequences from invertebrates resulted in more than 60 as hypertension [5], asthma [6] or smoking addiction additional ssRNA phage genome sequences [20]. In the [7], phage MS2 VLPs have been successfully used as car- majority of the partial genomes, an open reading frame riers for epitopes from the human papilloma virus [8], (ORF) between the conserved maturation and replicase while modifed phage AP205 VLPs have shown promis- genes can be identifed that putatively encodes a coat ing results as vaccine candidates against West Nile virus protein, although the ORFs show great variation in length [9]. Te ssRNA phage VLP technology has been further and sequence and in numerous cases no similarity to the extended for encapsulation of both macromolecular and known ssRNA phage CPs or any other proteins. small-molecule substances of interest inside the parti- While the metagenomic studies have greatly expanded cles, which in combination with VLP surface modifca- the known ssRNA phage diversity, infectious phages can- tion allows for the development of targeted bioimaging not be resurrected from the partial genome sequences, and drug delivery agents (see [10, 11] for comprehensive and their host bacteria, along with many other aspects reviews). ssRNA phage CPs and VLPs have also found of their biology, remain unknown. However, the CPs a number of applications as tools for molecular biology of the previously studied ssRNA phages have been able research, notably in generation of peptide display librar- to assemble into VLPs in absence of other phage com- ies [12], identifcation of protein–RNA interactions [13, ponents, which provides an opportunity to obtain and 14] and real-time imaging of RNA molecules in living study ssRNA phage VLPs even if the CP sequence is the cells [15]. only available information. In this study, we acquired Up to recently, the number of known ssRNA phages 110 putative ssRNA phage CP-encoding ORFs from the has been rather small. All of the currently identifed metagenomic data using gene synthesis, and here we phages use various Proteobacteria as their hosts; the report the expression, purifcation and characterization great majority of these infect Escherichia coli and related of 80 novel ssRNA phage VLPs. Enterobacteria, while the remaining few target bacteria of the Pseudomonas, Acinetobacter or Caulobacter genera. Results Te CPs of the Enterobacteria- and Pseudomonas-spe- CP similarity analysis cifc phages share very low, yet still detectable sequence Based on multiple sequence alignment, the previously similarity, while those from the Acinetobacter and Cau- known ssRNA phage CPs can be divided into three lobacter phages, of which only a single representative of broad similarity groups represented by the Enterobac- each has been sequenced, have no sequence similarity to teria- and Pseudomonas-infecting phages, the Acine- other CPs [16, 17]. Te diferent CPs vary considerably tobacter phage AP205 [16] and the Caulobacter phage both in their overall amenability for modifcation and for Cb5 [17], respectively. To reassess the ssRNA phage tolerance of particular foreign sequences, as well as in CP diversity in light of the new data, we compiled for their capability to recognize specifc RNA for encapsula- comparison a set of all of the published CP sequences tion and the stability of the assembled VLPs. Oftentimes, together with some additional ones that could be for a particular antigen a number of diferent VLP carri- located in NCBI’s nucleotide databases. However, for ers and modifcation strategies have to be screened until the CP sequences from the metagenomic data, a mul- a suitable one, if any, is found. In vaccine development tiple sequence alignment was deemed unreliable due and related areas, the immune response against the car- to the often very weak sequence similarity and broadly rier coat protein has also to be taken into account, and a variant protein length that ranged from 105 to 208 narrow range of available CPs adversely limits the num- residues compared to only 122 to 132 in the previ- ber of potential vaccines that could be produced using ously known phages. All available ssRNA phage CP the ssRNA phage platform. Discovery and characteriza- sequences were therefore subjected

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    14 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us